Nidan Laboratories and Healthcare Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Nidan Laboratories and Healthcare has a total shareholder equity of ₹662.1M and total debt of ₹124.3M, which brings its debt-to-equity ratio to 18.8%. Its total assets and total liabilities are ₹825.5M and ₹163.4M respectively. Nidan Laboratories and Healthcare's EBIT is ₹35.8M making its interest coverage ratio -6.4. It has cash and short-term investments of ₹28.5M.
Belangrijke informatie
18.8%
Verhouding schuld/eigen vermogen
₹124.35m
Schuld
| Rente dekkingsratio | -6.4x |
| Contant | ₹28.50m |
| Aandelen | ₹662.06m |
| Totaal verplichtingen | ₹163.45m |
| Totaal activa | ₹825.51m |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: NIDAN's short term assets (₹302.8M) exceed its short term liabilities (₹113.2M).
Langlopende schulden: NIDAN's short term assets (₹302.8M) exceed its long term liabilities (₹50.2M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: NIDAN's net debt to equity ratio (14.5%) is considered satisfactory.
Schuld verminderen: NIDAN's debt to equity ratio has reduced from 311.9% to 18.8% over the past 5 years.
Schuldendekking: NIDAN's operating cash flow is negative, therefore debt is not well covered.
Rentedekking: NIDAN earns more interest than it pays, so coverage of interest payments is not a concern.